FDA NDC Directory · JSON-LD · Markdown

Influenzinum

NDC 0220-5182 · HUMAN OTC DRUG · PELLET

Generic nameINFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Labeler / ManufacturerBoiron
Marketing categoryUNAPPROVED HOMEOPATHIC
Dosage form / routePELLET · ORAL
Active ingredientsINFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (9 [hp_C]/9[hp_C])
INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (9 [hp_C]/9[hp_C])
INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (9 [hp_C]/9[hp_C])
Marketing started20260914
Package count2

External sources

Source: openFDA. Public-domain (CC0).